Effects of agomelatine on rat liver regeneration following partial hepatectomy. 2023

A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey.

Primary or metastatic hepatic malignancies are common. Partial hepatectomy (PH) is the primary treatment for both benign and malignant hepatic neoplasms; it also is used for living donor liver transplantation. The regenerative potential of the liver after PH is 70-80% in humans. We investigated the protective and therapeutic effects of agomelatine (AGM) on rat liver regeneration following PH. We used 32 rats distributed equally into four groups: group 1, sham control; group 2, PH group; group 3, administered 20 mg/kg AGM orally once/day for 7 days following PH; group 4, administered 20 mg/kg AGM orally once/day 3 days before and 7 days following PH for 10 days. Liver samples were analyzed for antioxidants and free radicals. Tissue samples were processed and stained with hematoxylin and eosin to assess histopathological status and stained immunohistochemically for Ki-67. We found that PH reduced antioxidant enzymes and increased tissue reactive oxygen species, whereas AGM treatment had the opposite effect on these parameters. Our biochemical and histopathological findings were consistent. PH caused sinusoid congestion and dilation. Intensity of Ki-67 immunostaining of hepatocytes was increased in group 2, whereas these were reduced in group 4. Intensity of Ki-67 immunostaining of hepatocytes was increased in group 2, whereas it was reduced in the group 4 compared to group 1. We found that AGM was hepatoprotective following PH due to its antioxidant and free radical scavenger properties.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008115 Liver Regeneration Repair or renewal of hepatic tissue. Liver Regenerations,Regeneration, Liver,Regenerations, Liver
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019394 Ki-67 Antigen A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells. Antigen Ki-67,MIB-1 Antigen,Antigen Ki67,Antigen Ki 67,Antigen, Ki-67,Antigen, MIB-1,Ki 67 Antigen,Ki-67, Antigen,Ki67, Antigen,MIB 1 Antigen
D019520 Living Donors Non-cadaveric providers of organs for transplant to related or non-related recipients. Donors, Living,Donor, Living,Living Donor

Related Publications

A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
February 1992, Clinical science (London, England : 1979),
A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
January 1958, Rivista di gastro-enterologia,
A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
November 1971, Cell and tissue kinetics,
A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
April 2004, The Journal of surgical research,
A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
January 1964, Kiserletes orvostudomany,
A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
January 1984, Hepatology (Baltimore, Md.),
A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
January 1977, Voprosy meditsinskoi khimii,
A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
June 1967, Die Naturwissenschaften,
A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
April 1979, The Biochemical journal,
A Kose, and O Ozhan, and H Parlakpinar, and N Vardi, and A Yildiz, and Y Turkoz, and Z Erdemli, and Y Bilgic, and M E Sarihan
March 1991, Biochemistry international,
Copied contents to your clipboard!